Pasithea Therapeutics (KTTA) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Pasithea Therapeutics (KTTA) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 27, 2024 (17:48)

Sector: Healthcare

The share price of Pasithea Therapeutics Corp. (KTTA) now

Latest session on the 24th of May for
Pasithea Therapeutics Corp. is negative
Trading Volume: 2487
Open: 6.58 /  High: 6.78 /  Low: 6.4
What analysts predict: $2
52-week High/Low: $12.82 / $5.26

50/200 Day Moving Average: $7.17 / $7.93

This figure corresponds to the Average Price over the previous 50/200 days. For Pasithea Therapeutics stocks, the 50-day moving average is the resistance level today.

For Pasithea Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Pasithea Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pasithea Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Pasithea Therapeutics share be worth in 2024 - 2028?

When should I take profit in Pasithea Therapeutics stock? When should I record a loss on Pasithea Therapeutics stock? What are analysts' forecasts for Pasithea Therapeutics stock? What is the future of Pasithea Therapeutics stock? We forecast Pasithea Therapeutics stock performance using neural networks based on historical data on Pasithea Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Pasithea Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Pasithea Therapeutics shares. This happens once a day.


Historical and forecast chart of Pasithea Therapeutics stock

The chart below shows the historical price of Pasithea Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Pasithea Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Pasithea specializes in the discovery and development of new drugs for the treatment of psychiatric and neurological disorders. The company does not currently have a leading candidate drug in development. In the 24 months following its IPO, the company plans to discover three leading candidate compounds targeting the immune system’s link to certain mental disorders. An additional Pasithea business is to open depression clinics in the UK and the US, where doctors will administer ketamine intravenously to patients when indicated.

Pasithea Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 29 7.12 6.92 7.37 6.55
May 30 6.99 6.63 7.25 9.21
May 31 7.01 6.90 7.21 4.48
Jun 01 7.07 6.68 7.23 8.29
Jun 02 7.49 7.19 7.63 6.05
Jun 03 7.75 7.36 7.87 7.01
Jun 04 7.84 7.64 7.98 4.45
Jun 05 7.64 7.52 8.00 6.32
Jun 06 7.31 6.94 7.62 9.72
Jun 07 6.95 6.68 7.34 9.83
Jun 08 7.08 6.92 7.48 8.10
Jun 09 7.36 6.95 7.70 10.74
Jun 10 7.25 7.07 7.49 5.96
Jun 11 7.26 6.98 7.59 8.74
Jun 12 7.04 6.86 7.36 7.26
Jun 13 6.94 6.68 7.06 5.74
Jun 14 6.76 6.40 7.02 9.77
Jun 15 6.63 6.43 6.80 5.70
Jun 16 6.68 6.45 6.86 6.31
Jun 17 6.91 6.54 7.29 11.39
Jun 18 6.75 6.50 6.93 6.69
Jun 19 6.35 6.02 6.56 8.93
Jun 20 6.73 6.42 7.04 9.69
Jun 21 6.55 6.19 6.72 8.51
Jun 22 6.45 6.18 6.59 6.73
Jun 23 6.69 6.58 7.05 7.19
Jun 24 6.38 6.17 6.51 5.50
Jun 25 6.08 5.86 6.32 7.69
Jun 26 5.80 5.72 6.09 6.53
Jun 27 5.98 5.69 6.19 8.67

Pasithea Therapeutics Daily Price Targets


Pasithea Therapeutics Stock Forecast 05-29-2024.

Forecast target price for 05-29-2024: $7.12.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 6.151%.
Pessimistic target level: 6.92
Optimistic target level: 7.37

Pasithea Therapeutics Stock Forecast 05-30-2024.

Forecast target price for 05-30-2024: $6.99.
Negative dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 8.437%.
Pessimistic target level: 6.63
Optimistic target level: 7.25

Pasithea Therapeutics Stock Forecast 05-31-2024.

Forecast target price for 05-31-2024: $7.01.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 4.287%.
Pessimistic target level: 6.90
Optimistic target level: 7.21

Pasithea Therapeutics Stock Forecast 06-01-2024.

Forecast target price for 06-01-2024: $7.07.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 7.658%.
Pessimistic target level: 6.68
Optimistic target level: 7.23

Pasithea Therapeutics Stock Forecast 06-02-2024.

Forecast target price for 06-02-2024: $7.49.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 5.706%.
Pessimistic target level: 7.19
Optimistic target level: 7.63

Pasithea Therapeutics Stock Forecast 06-03-2024.

Forecast target price for 06-03-2024: $7.75.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 6.549%.
Pessimistic target level: 7.36
Optimistic target level: 7.87

KTTA (KTTA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 7.21 6.24 7.56 17.43
Jul. 6.92 6.38 7.46 14.42
Aug. 6.19 5.31 7.22 26.48
Sep. 6.71 5.66 7.77 27.21
Oct. 7.29 6.51 7.87 17.31
Nov. 7.97 7.45 9.12 18.34
Dec. 8.99 8.50 10.14 16.20

Pasithea Therapeutics forecast for this year


Pasithea Therapeutics Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $7.20852. Pessimistic: $6.24. Optimistic: $7.56


Pasithea Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $6.9209. Pessimistic: $6.38. Optimistic: $7.46


Pasithea Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $6.19421. Pessimistic: $5.31. Optimistic: $7.22


Pasithea Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $6.71452. Pessimistic: $5.66. Optimistic: $7.77


Pasithea Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $7.29264. Pessimistic: $6.51. Optimistic: $7.87


Pasithea Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $7.96648. Pessimistic: $7.45. Optimistic: $9.12


Pasithea Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $8.98698. Pessimistic: $8.50. Optimistic: $10.14



Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 9.87 9.09 11.04 17.66
Feb 9.75 9.30 10.47 11.15
Mar 10.47 9.50 11.17 14.95
Apr 9.26 8.01 9.92 19.21
May 9.18 8.64 10.20 15.31
Jun 10.53 9.11 12.10 24.67
Jul 9.82 8.81 11.16 21.07
Aug 10.58 10.07 11.47 12.21
Sep 10.16 9.27 10.67 13.19
Oct 11.25 10.66 12.15 12.25
Nov 12.88 12.31 14.56 15.42
Dec 12.69 11.36 14.74 22.96

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 10.43 8.92 11.26 20.81
Feb 10.54 9.67 11.86 18.46
Mar 9.96 8.96 11.47 21.89
Apr 9.75 8.11 11.27 27.99
May 11.53 10.42 13.37 22.09
Jun 13.74 13.07 15.38 15.00
Jul 13.36 11.62 15.44 24.72
Aug 15.24 12.87 16.49 21.93
Sep 12.62 11.40 14.29 20.22
Oct 11.66 10.29 12.23 15.83
Nov 11.74 10.60 12.30 13.82
Dec 12.62 11.75 13.47 12.79

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 11.48 11.00 12.64 12.97
Feb 10.33 9.48 11.58 18.16
Mar 11.50 10.80 12.90 16.29
Apr 13.36 12.52 14.06 10.97
May 13.92 11.58 15.61 25.83
Jun 15.38 12.92 17.35 25.50
Jul 14.44 12.93 16.26 20.52
Aug 13.47 12.28 14.41 14.73
Sep 14.89 13.04 16.17 19.34
Oct 11.76 10.38 12.50 16.99
Nov 10.72 10.00 11.31 11.55
Dec 10.18 9.11 11.68 21.97

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 11.17 10.32 11.99 13.89
Feb 13.07 12.21 14.22 14.09
Mar 14.08 13.08 15.97 18.14
Apr 14.23 12.23 15.90 23.11
May 16.83 14.35 18.28 21.46
Jun 15.20 13.48 17.69 23.82
Jul 15.04 13.62 16.15 15.65
Aug 18.14 17.30 19.51 11.32
Sep 19.09 16.40 21.82 24.81
Oct 19.73 18.12 22.18 18.31
Nov 15.71 14.82 17.96 17.46
Dec 13.54 12.17 14.81 17.84

Pasithea Therapeutics information and performance

Pasithea Therapeutics Address

2110 NARCISSUS CT, VENICE, CA, US

Market Capitalization: 6 676 800 $

Market capitalization of the Pasithea Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KTTA shares in the company outstanding by the market price of one share.

EBITDA: -15 330 907 $

EBITDA of Pasithea Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -12.64

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 14.98
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 277.44

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.553

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1043200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.